Literature DB >> 12464640

Regulation of Epstein-Barr virus lytic cycle activation in malignant and nonmalignant disease.

I George Miller, Ayman El-Guindy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12464640     DOI: 10.1093/jnci/94.23.1733

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

1.  Epstein-Barr virus LF2 protein regulates viral replication by altering Rta subcellular localization.

Authors:  Andreas M F Heilmann; Michael A Calderwood; Eric Johannsen
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

2.  The Epstein-Barr virus LF2 protein inhibits viral replication.

Authors:  Michael A Calderwood; Amy M Holthaus; Eric Johannsen
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

3.  Genome-wide analysis of Epstein-Barr virus Rta DNA binding.

Authors:  Andreas M F Heilmann; Michael A Calderwood; Daniel Portal; Yong Lu; Eric Johannsen
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

4.  Genome-wide analyses of Zta binding to the Epstein-Barr virus genome reveals interactions in both early and late lytic cycles and an epigenetic switch leading to an altered binding profile.

Authors:  Sharada Ramasubramanyan; Aditi Kanhere; Kay Osborn; Kirsty Flower; Richard G Jenner; Alison J Sinclair
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

5.  Epstein-Barr virus BNRF1 destabilizes SMC5/6 cohesin complexes to evade its restriction of replication compartments.

Authors:  Stephanie Pei Tung Yiu; Rui Guo; Cassie Zerbe; Michael P Weekes; Benjamin E Gewurz
Journal:  Cell Rep       Date:  2022-03-08       Impact factor: 9.423

6.  Interpretation of EBV infection in pan-cancer genome considering viral life cycle: LiEB (Life cycle of Epstein-Barr virus).

Authors:  Hyojin Song; Yoojoo Lim; Hogune Im; Jeong Mo Bae; Gyeong Hoon Kang; Junhak Ahn; Daehyun Baek; Tae-You Kim; Sung-Soo Yoon; Youngil Koh
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.